The Institute for Cancer Genetics was founded in 1999 as part of a commitment by Columbia University to examine the molecular mechanisms and pathogenesis of cancer. Researchers within the Institute use traditional approaches such as transgenic mice to model human cancers and also take advantage of new technology such as DNA Chip microarrays to identify and characterize key proteins involved in the process of tumor initiation and progression.